| Probiotics in the treatment of human inflammatory bowel diseases: update 2011. | |
| | |
MedLine Citation:
|
PMID: 21992953 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Crohn's disease, ulcerative colitis, and pouchitis after ileal pouch anal anastomosis in ulcerative colitis patients are often refractory to standard therapy. Over the last decade, the rational to use probiotics and its beneficial efficacy in the treatment of chronic inflammatory bowel disease (IBD) is increasingly under scrutiny. Although it has become clear that intestinal epithelial-mucosal immune interactions and enteric bacteria play a critical role in the development of IBD, the substantial clinical efficacy of probiotics in these disorders is less evident. This review outlines the clinical studies regarding probiotics before October 2007. These studies formed the foundation of probiotic clinical trials in IBD, but they also indicated the need of larger and better-controlled studies than the past experimental approaches. Furthermore, this review also examines in-depth the probiotic clinical trials published between 2007 and December 2010, providing new insights into the role of probiotics for inducing and maintaining remission of IBD, and highlighting some of the breakthroughs, especially regarding induction of remission for ulcerative colitis. |
| | |
Authors:
|
Bartolomeus Joannes Meijer; Levinus Albert Dieleman |
Related Documents
:
|
8098953 - Nmr spectroscopy of human post mortem cerebrospinal fluid: distinction of alzheimer's d... 16425673 - Ispronicline (targacept). 12003713 - Inflammatory bowel disease in children. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of clinical gastroenterology Volume: 45 Suppl ISSN: 1539-2031 ISO Abbreviation: J. Clin. Gastroenterol. Publication Date: 2011 Nov |
Date Detail:
|
Created Date: 2011-10-13 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7910017 Medline TA: J Clin Gastroenterol Country: United States |
Other Details:
|
Languages: eng Pagination: S139-44 Citation Subset: IM |
Affiliation:
|
Department of Medicine, Center of Excellence for Gastrointestinal Inflammation and Immunity Research, University of Alberta, Edmonton, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Probiotics in the prevention of necrotizing enterocolitis.
Next Document: The rationale and clinical effectiveness of probiotics in irritable bowel syndrome.